Kosch A - Search Results

1

The factor V G1691A mutation is a risk for porencephaly: A case-control study.

Debus OM, Kosch A, Sträter R, Rossi R, Nowak-Göttl U. Debus OM, et al. Among authors: kosch a. Ann Neurol. 2004 Aug;56(2):287-90. doi: 10.1002/ana.20184. Ann Neurol. 2004. PMID: 15293282

2

Thromboembolism in children.

Nowak-Göttl U, Kosch A, Schlegel N, Salem M, Manco-Johnson M. Nowak-Göttl U, et al. Among authors: kosch a. Curr Opin Hematol. 2002 Sep;9(5):448-53. doi: 10.1097/00062752-200209000-00010. Curr Opin Hematol. 2002. PMID: 12172465 Review.

3

Neonatal thromboembolism.

Nowak-Göttl U, Kosch A, Schlegel N. Nowak-Göttl U, et al. Among authors: kosch a. Semin Thromb Hemost. 2003 Apr;29(2):227-34. doi: 10.1055/s-2003-38839. Semin Thromb Hemost. 2003. PMID: 12709927 Review.

4

Recurrent thromboembolism in infants and children suffering from symptomatic neonatal arterial stroke: a prospective follow-up study.

Kurnik K, Kosch A, Sträter R, Schobess R, Heller C, Nowak-Göttl U; Childhood Stroke Study Group. Kurnik K, et al. Among authors: kosch a. Stroke. 2003 Dec;34(12):2887-92. doi: 10.1161/01.STR.0000103745.03393.39. Epub 2003 Nov 20. Stroke. 2003. PMID: 14631084

5

Increased fasting total homocysteine plasma levels as a risk factor for thromboembolism in children.

Kosch A, Koch HG, Heinecke A, Kurnik K, Heller C, Nowak-Göttl U; Childhood Thrombophilia Study Group. Kosch A, et al. Thromb Haemost. 2004 Feb;91(2):308-14. doi: 10.1160/TH03-02-0038. Thromb Haemost. 2004. PMID: 14961159

6

Renal venous thrombosis in neonates: prothrombotic risk factors and long-term follow-up.

Kosch A, Kuwertz-Bröking E, Heller C, Kurnik K, Schobess R, Nowak-Göttl U. Kosch A, et al. Blood. 2004 Sep 1;104(5):1356-60. doi: 10.1182/blood-2004-01-0229. Epub 2004 May 18. Blood. 2004. PMID: 15150075 Free article.

7

Factor VIII, D-Dimer, and thromboembolism in children.

Nowak-Göttl U, Kosch A. Nowak-Göttl U, et al. Among authors: kosch a. N Engl J Med. 2004 Sep 9;351(11):1051-3. doi: 10.1056/NEJMp048150. N Engl J Med. 2004. PMID: 15356301 No abstract available.

8

Total tissue factor pathway inhibitor is an independent risk factor for symptomatic paediatric venous thromboembolism and stroke.

Duering C, Kosch A, Langer C, Thedieck S, Nowak-Göttl U. Duering C, et al. Among authors: kosch a. Thromb Haemost. 2004 Oct;92(4):707-12. doi: 10.1160/TH04-05-0293. Thromb Haemost. 2004. PMID: 15467899

9

Prothrombotic risk factors in children with spontaneous venous thrombosis and their asymptomatic parents: a family study.

Kosch A, Junker R, Kurnik K, Schobess R, Günther G, Koch H, Nowak-Göttl U. Kosch A, et al. Thromb Res. 2000 Sep 15;99(6):531-7. doi: 10.1016/s0049-3848(00)00287-5. Thromb Res. 2000. PMID: 10974337

10

The plasminogen activator inhibitor (PAI)-1 promoter 4G/4G genotype is not associated with ischemic stroke in a population of German children. Childhood Stroke Study Group.

Nowak-Göttl U, Sträter R, Kosch A, von Eckardstein A, Schobess R, Luigs P, Nabel P, Vielhaber H, Kurnik K, Junker R. Nowak-Göttl U, et al. Among authors: kosch a. Eur J Haematol. 2001 Jan;66(1):57-62. doi: 10.1034/j.1600-0609.2001.00338.x. Eur J Haematol. 2001. PMID: 11168509

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

22 results

Search Page

Filters